Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review

Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review

Since myeloproliferative neoplasms (MPN) pose a significant risk for vascular and thrombotic complications, cytoreductive therapies, such as hydroxyurea (HU), interferon (IFN) inhibitors, and Janus kinase (JAK) inhibitors are recommended for patients at high risk. However, these agents also place pa...

Full description

Bibliographic Details
Main Authors: Alessandra Malato, Elena Rossi, Giuseppe Alberto Palumbo, Paola Guglielmelli, Novella Pugliese
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
adverse events
Philadelphia chromosome-negative myeloproliferative neoplasms
cytoreductive agents
Online Access:https://www.mdpi.com/1422-0067/21/11/3900

Similar Items

Similar Items